Bristol-Myers Squibb (BMY) Tops Q3 EPS by 10c, Updattes FY Guidance
Tweet Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
